NCT00129519View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Basal Cell Carcinoma
Interventions
DRUG

Imiquimod 5% cream

Imiquimod 5% cream applied once daily 5x/week for up to 6 weeks

Trial Locations (3)

10016

New York

92354

Loma Linda

95945

Grass Valley

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY